Ross Wanner

458 total citations
13 papers, 365 citations indexed

About

Ross Wanner is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ross Wanner has authored 13 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Ross Wanner's work include Extracellular vesicles in disease (5 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). Ross Wanner is often cited by papers focused on Extracellular vesicles in disease (5 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). Ross Wanner collaborates with scholars based in United States, Japan and Georgia. Ross Wanner's co-authors include Uksha Saini, Karuppaiyah Selvendiran, David E. Cohn, Kalpana Deepa Priya Dorayappan, John Wallbillich, Roman A. Zingarelli, Adrian A. Suarez, Shan K. Naidu, Kristin Bixel and Paul J. Goodfellow and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Ross Wanner

13 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ross Wanner United States	6	266	197	89	63	34	13	365
Da Zeng China	9	187 0.7×	111 0.6×	89 1.0×	87 1.4×	24 0.7×	22	344
Hiroe Nakamura Japan	12	182 0.7×	113 0.6×	124 1.4×	74 1.2×	29 0.9×	29	365
Yan C. Wang United States	6	234 0.9×	123 0.6×	173 1.9×	84 1.3×	20 0.6×	9	394
Gudrun Hager Austria	11	171 0.6×	109 0.6×	110 1.2×	29 0.5×	44 1.3×	14	354
Sinéad Lindsay Ireland	7	321 1.2×	179 0.9×	59 0.7×	54 0.9×	15 0.4×	7	400
Martyna Pakuła Poland	10	143 0.5×	57 0.3×	91 1.0×	45 0.7×	46 1.4×	15	289
Keqi Song China	9	234 0.9×	174 0.9×	46 0.5×	22 0.3×	40 1.2×	12	325
Wanrong Wu China	12	235 0.9×	187 0.9×	46 0.5×	56 0.9×	12 0.4×	19	335
Shanshan Zhao China	13	351 1.3×	258 1.3×	40 0.4×	28 0.4×	18 0.5×	27	486
Michela Romano Italy	9	180 0.7×	104 0.5×	120 1.3×	25 0.4×	49 1.4×	11	370

Countries citing papers authored by Ross Wanner

Since Specialization

Citations

This map shows the geographic impact of Ross Wanner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Wanner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Wanner more than expected).

Fields of papers citing papers by Ross Wanner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Wanner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Wanner. The network helps show where Ross Wanner may publish in the future.

Co-authorship network of co-authors of Ross Wanner

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Wanner. A scholar is included among the top collaborators of Ross Wanner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Wanner. Ross Wanner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Sakaue, Takahiko, Kalpana Deepa Priya Dorayappan, Roman A. Zingarelli, et al.. (2024). Obesity-induced extracellular vesicles proteins drive the endometrial cancer pathogenesis: therapeutic potential of HO-3867 and Metformin. Oncogene. 43(49). 3586–3597. 3 indexed citations

Silverman, Dustin A., Sean McDermott, Ross Wanner, et al.. (2021). Meta-Analysis illustrates possible role of lipopolysaccharide (LPS)-induced tissue injury in nasopharyngeal carcinoma (NPC) pathogenesis. PLoS ONE. 16(10). e0258187–e0258187. 2 indexed citations

McDermott, Sean, et al.. (2019). Meta-analysis Illustrates the Genetic Signature Underlying Allergic Rhinitis Pathophysiology and Potential Therapeutic Targets. Journal of Allergy and Clinical Immunology. 143(2). AB185–AB185. 1 indexed citations

Saini, Uksha, Adrian A. Suarez, Shan K. Naidu, et al.. (2018). STAT3/PIAS3 Levels Serve as “Early Signature” Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube. Cancer Research. 78(7). 1739–1750. 17 indexed citations

Dorayappan, Kalpana Deepa Priya, Ross Wanner, John Wallbillich, et al.. (2018). Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins. Oncogene. 37(28). 3806–3821. 243 indexed citations

Smith, B., Kalpana Deepa Priya Dorayappan, Roman A. Zingarelli, et al.. (2018). Aberrant TMEM205-CD1B signaling promotes platinum resistance in ovarian cancer. Gynecologic Oncology. 149. 65–65. 1 indexed citations

Dorayappan, Kalpana Deepa Priya, Roman A. Zingarelli, Colin L. Hisey, et al.. (2018). Evaluating exosome proteins as biomarkers for the early detection of high-grade serous ovarian cancer. Gynecologic Oncology. 149. 71–71. 1 indexed citations

Wallbillich, John, Srirama Josyula, Uksha Saini, et al.. (2017). High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer. PLoS ONE. 12(1). e0170318–e0170318. 30 indexed citations

Bixel, Kristin, Uksha Saini, Hemant K. Bid, et al.. (2017). Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinoma. International Journal of Cancer. 141(9). 1856–1866. 29 indexed citations

10.

Dorayappan, Kalpana Deepa Priya, John Wallbillich, Kristin Bixel, et al.. (2016). Hypoxia-facilitated exosomal release from ovarian cancer cells is regulated by STAT3 and is associated with increased metastatic tumor burden. Gynecologic Oncology. 141. 66–66. 2 indexed citations

11.

ElNaggar, Adam C., Uksha Saini, Shan K. Naidu, et al.. (2016). Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and H-4318, in cisplatin resistant primary ovarian cancer. Cancer Biology & Therapy. 17(10). 1107–1115. 17 indexed citations

12.

Bixel, Kristin, Jim Fowler, Ross Wanner, et al.. (2015). Abstract 3: Inhibition of STAT3 in ovarian clear cell carcinoma results in decreased cell proliferation and induction of apoptosis. Gynecologic Oncology. 137(3). 592–592. 1 indexed citations

13.

Tierney, Brent J., Georgia A. McCann, Shan K. Naidu, et al.. (2014). Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor. Gynecologic Oncology. 135(1). 133–141. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact